Literature DB >> 2294778

Thymic carcinomas: histopathological varieties and immunohistochemical study.

T T Kuo1, J P Chang, F J Lin, W C Wu, C H Chang.   

Abstract

Thirteen cases of primary thymic carcinomas are described. The patients' ages ranged from 19 to 64 years, with a median of 40 years. Nine of them were male. Chest pain with or without cough was the main presenting symptom. No patient had myasthenia gravis. Five histological types were identified; two were undifferentiated (lymphoepithelioma-like) carcinoma, one was a clear-cell carcinoma, two were mixed squamous and small-cell carcinoma, and six were squamous cell carcinoma. All the tumors were variably positive for anti-keratin antibody AE1 and AE3, but negative for AE2. Anti-neuron specific enolase antibody was useful in identifying and confirming the small-cell carcinoma component of the mixed carcinomas. Anti-epithelial membrane antigen antibody aided in revealing the glandular structures in mixed adenosquamous and small-cell carcinomas. Thymic carcinomas were histopathologically differentiated from thymomas by their malignant cytological appearance, increased mitotic activity, and central tumor necrosis. All six patients with pure squamous-cell carcinoma were still alive, with a median survival time of 27 months. All but one of the other patients of different histological types died, the exception being a recent case of mixed adenosquamous and small-cell carcinoma; their median survival was 19.5 months, or 18 months when the latter surviving case is included. The prognosis of patients with pure squamous-cell carcinoma was better.

Entities:  

Mesh:

Year:  1990        PMID: 2294778

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  14 in total

1.  Tumour eosinophilia combined with an immunohistochemistry panel is useful in the differentiation of type B3 thymoma from thymic carcinoma.

Authors:  Thaer Khoury; Rameela Chandrasekhar; Gregory Wilding; Dongfeng Tan; Richard T Cheney
Journal:  Int J Exp Pathol       Date:  2010-11-02       Impact factor: 1.925

Review 2.  Neuroendocrine tumors of the thymus and mediastinum.

Authors:  Hanibal Bohnenberger; Helen Dinter; Alexander König; Philipp Ströbel
Journal:  J Thorac Dis       Date:  2017-11       Impact factor: 2.895

3.  Development of combined thymic carcinoma and thymoma in an extrathymic lesion during long follow-up for recurrent thymoma.

Authors:  Yasuhiro Ohue; Shunichiro Matsuoka; Hirotaka Kumeda; Hiroyuki Agatsuma; Akira Hyougotani; Masayuki Toishi; Takayuki Shiina; Kazuo Yoshida; Kunihiko Shingu; Toshirou Fukushima; Tomonobu Koizumi
Journal:  Mol Clin Oncol       Date:  2015-12-11

4.  CD138 (Syndecan-1) in thymic tumors: correlation with various World Health Organization types and clinical outcome.

Authors:  Osama M Al-Agha; Weiguo Liu; Rameela Chandrasekhar; Gregory Wilding; Dongfeng Tan; Sadir Alrawi; Thaer Khoury
Journal:  Int J Clin Exp Pathol       Date:  2010-02-10

5.  A case of successful preoperative chemotherapy with cisplatin and irinotecan followed by curative-intent surgery for locally advanced thymic carcinoma.

Authors:  Shigeki Suzuki; Hirotoshi Horio; Tai Hato; Masahiko Harada; Yusuke Okuma; Tsunekazu Hishima
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-07-04

6.  Thymoma: tumour type related to expression of epidermal growth factor (EGF), EGF-receptor, p53, v-erb B and ras p21.

Authors:  Y Hayashi; N Ishii; C Obayashi; K Jinnai; K Hanioka; Y Imai; H Itoh
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

7.  Well-differentiated thymic carcinoma: a clinico-pathological study.

Authors:  E Pescarmona; S Rosati; E A Rendina; F Venuta; C D Baroni
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

Review 8.  [Neuroendocrine neoplasms of the mediastinum].

Authors:  L Brcic; M Heidinger; H Popper
Journal:  Pathologe       Date:  2016-09       Impact factor: 1.011

9.  CD5 expression in thymic carcinoma.

Authors:  T Hishima; M Fukayama; M Fujisawa; Y Hayashi; K Arai; N Funata; M Koike
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

10.  Thymic carcinoma with brain metastasis mimicking meningioma.

Authors:  Jung Yong Ahn; Nam Keun Kim; Doyeun Oh; Hui Jung Ahn
Journal:  J Neurooncol       Date:  2002-07       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.